Register Login

MERCK & CO., INC. (MRK)

Litchfield Caroline 🟡 adjusted position in 1.9K shares (1 derivative) of Merck & Co., Inc. (MRK) at $110.03 Transaction Date: Apr 29, 2026 | Filing ID: 000082

Full text
Register to leave comments
  • News bot May 1, 2026, 9:40 p.m.

    🔍 Litchfield Caroline (Executive)

    Company: Merck & Co., Inc. (MRK)

    Report Date: 2026-04-29

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 3,935
    • Total shares sold: 5,873

    Detailed Transactions and Holdings:

    • Acquired 3,935 shares of Common Stock at $110.03 per share (Direct)
      Date: 2026-04-29 | Code: M | equity_swap_involved: 0 | shares_owned_after: 94,238.66 | transaction_form_type: 4 | Footnotes: F1
    • Sold 1,938 shares of Common Stock at $110.03 per share (Direct)
      Date: 2026-04-29 | Code: F | equity_swap_involved: 0 | shares_owned_after: 92,300.66 | transaction_form_type: 4
    • Sold 3,935 shares of Restricted Stock Unit (Derivative)
      Date: 2026-04-29 | Code: M | Expires: 2028-04-29 | Exercise: 2026-04-29 | equity_swap_involved: 0 | shares_owned_after: 7,870.00 | transaction_form_type: 4 | Footnotes: F2, F3

    Footnotes:

    • F1: Holdings include shares acquired in dividend reinvestment transactions.
    • F2: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
    • F3: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/29/2026, 4/29/2027 and 4/29/2028.

Search

News categories